Get started
Author

Michael Monrad Grandal

Observed names: M Grandal, Michael Grandal, Michael M Grandal, Michael M. Grandal
ORCID: 0000-0001-5434-9978
Observed ORCID: 0000-0001-5434-9978
OpenAlex ID: A5017048505
Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
2008 · Kirstine Roepstorff, Lene Grøvdal, et al. · Histochemistry and Cell Biology · 208
PDF
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
2018 · Clara Montagut, Guillem Argilés, et al. · JAMA Oncology · 141
PDF
Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way
2005 · Mads Lerdrup, Anette M. Hommelgaard, et al. · Journal of Cell Science · 72
Sym015: A Highly Efficacious Antibody Mixture against MET -Amplified Tumors
2017 · Thomas Tuxen Poulsen, Michael Monrad Grandal, et al. · Clinical Cancer Research · 49
A combination of two antibodies recognizing non‐overlapping epitopes of HER 2 induces kinase activity‐dependent internalization of HER 2
2016 · Monika Szymanska, Anne M. Fosdahl, et al. · Journal of Cellular and Molecular Medicine · 37
PDF
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform
2019 · Torben Gjetting, Monika Gad, et al. · mAbs · 34
PDF
Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms
2017 · Michael M. Grandal, Serhiy Havrylov, et al. · Molecular Cancer Therapeutics · 28
Pan‐HER—An antibody mixture targeting EGFR, HER2 and HER3 abrogates preformed and ligand‐induced EGFR homo‐ and heterodimers
2016 · Sofie Ellebæk, Susanne Brix, et al. · International Journal of Cancer · 23
PDF
[Prevalence of porphyria cutanea tarda in Madrid and relationship between urine porphyrin and ethanol intake in a multiple linear regression model].
1996 · J L Santos, M Grandal, et al. · PubMed · 11
Abstract 5626: Preclinical characterization of Sym022, a novel anti-LAG3 antibody
2018 · Michael M. Grandal, Maria C. Melander, et al. · Cancer Research · 8
Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models
2018 · Stephen T. Keir, Vidyalakshmi Chandramohan, et al. · Journal of Neuro-Oncology · 8
PDF
Abstract 3737: Molecular and early clinical characterization of the anti-CD73 antibody S095024 (Sym024)
2024 · Anna Spreafico, Jordi R. Ahnert, et al. · Cancer Research · 7
Abstract 1797: Preclinical characterization of Sym024, a novel anti-CD73 antibody
2021 · Janus S. Jakobsen, Matteo Riva, et al. · Cancer Research · 3
Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al. · Clinical Cancer Research · 2
Development of Inno8, an orally administered factor VIIIa-mimetic antibody fragment for treatment of hemophilia A
2026 · Jacob Lund, Jais Rose Bjelke, et al. · Blood
PDF
Supplementary Table S6 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S4 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S2 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S1 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S8 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S9 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S5 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S1 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Table S9 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Supplementary Figure S8 from Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti–PD-1 Therapy
2026 · Janus S. Jakobsen, Michael M. Grandal, et al.
Works count: 46
Citation count: 631
H-index: 9
I10-index: 9
Year
Topic
Type